• Digestive Transformations of Withania Bioactives

  2026-09-14

  The reference study integrates simulated gastrointestinal digestion with LC–MS/MS profiling, untargeted metabolomics, and molecular networking to determine how Withania somnifera leaf and root metabolites change before absorption. Its results distinguish labile compounds, including withaferin A and withanoside IV, from the comparatively stable withanolide A and show why botanical pharmacokinetic models must account for extract type and digestive transformation.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-09-14

  The CFDA SE Cell Tracer Kit supports stable fluorescent labeling for cell lineage tracing, cell proliferation studies, and in vitro or in vivo tracking workflows. It is appropriate when durable covalent marking is needed, but not for reversible labeling, short-term signal readouts, or immediate physiological measurements.

• Z-VEID-FMK for Reliable Caspase-6 Assays

  2026-09-13

  Learn how Z-VEID-FMK (SKU A1923) can support more interpretable apoptosis, viability, and caspase activity experiments. This scenario-driven guide covers mechanism, solvent compatibility, protocol design, cross-domain interpretation, and practical vendor-selection criteria.

• Octyl-α-ketoglutarate for HIF-1α Regulation

  2026-09-12

  Octyl-α-ketoglutarate provides a cell-permeable route to test whether α-ketoglutarate availability controls prolyl hydroxylase activity, HIF-1α stability, and metabolic phenotypes. This practical guide connects the reagent to IDH-driven colorectal cancer models, TCA cycle dysfunction research, and reproducible hypoxia assays.

• Cy3 NHS Ester (Non-Sulfonated): Practical Guide

  2026-09-11

  Cy3 NHS ester (non-sulfonated) provides orange fluorescence for amino-group labeling of proteins, peptides, and oligonucleotides when sensitive optical detection is required. It is best suited to workflows that can tolerate a DMSO, DMF, or ethanol co-solvent and is less suitable for delicate aqueous-only protein assays because the reagent is water-insoluble.

• KX2-391 Dihydrochloride: A Translational Playbook

  2026-09-11

  KX2-391 dihydrochloride, also known as Tirbanibulin dihydrochloride, illustrates how one small molecule can connect substrate-site Src inhibition, tubulin disruption, HBV transcriptional control, and emerging intracellular BoNT/A research. This thought-leadership guide translates the evidence into practical assay design, mechanism-aware interpretation, and a disciplined path from screening to translational decision-making.

• Early Life Adversity, Oxytocin, and Innate Defense

  2026-09-10

  This article in press identifies a superior colliculus oxytocin-signaling deficit as a mechanistic link between early life adversity and impaired looming-evoked innate defensive behavior in mice. The combination of developmental stress modeling, circuit analysis, receptor knockdown, and intranasal oxytocin rescue provides a framework for studying how early experience reshapes threat processing, while leaving important questions about generalizability and therapeutic translation.

• FAPα-Responsive Nanoparticles for Urinary Tumor Diagnosis

  2026-09-10

  Feng and colleagues developed magnetic iron oxide nanoparticles carrying a substrate–reporter peptide that is cleaved by fibroblast activation protein α in tumor tissue, releasing a detectable urinary signal. In an esophageal squamous cell carcinoma xenograft model, the platform combined tumor biodistribution imaging with urine ELISA and achieved an area under the ROC curve of 1.0, while remaining a preclinical diagnostic strategy rather than a validated clinical test.

• Baicalein Workflows for Cancer and Inflammation

  2026-09-09

  Build reproducible Baicalein assays around 12-LOX inhibition, apoptosis, inflammatory signaling, and cancer-cell phenotypes. This practical workflow also shows how to borrow assay logic from chemotherapy-neurotoxicity research without confusing evidence for formononetin with evidence for Baicalein.

• A-769662: AMPK Activator Workflow

  2026-09-09

  A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, autophagy signaling, and proteasome-linked cell-cycle phenotypes. This workflow emphasizes orthogonal readouts so researchers can separate genuine AMPK effects from the compound’s AMPK-independent proteasome activity.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-08

  Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a fluorescent mouse IgG detection antibody for visualizing mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It is intended for research use only; assay-specific dilution, background, sensitivity, and live-cell compatibility should be established experimentally rather than assumed.

• Plant Cell Lysis Buffer for WB and IP Workflow

  2026-09-08

  Build cleaner Western blots, native immunoprecipitations, and co-IP assays from challenging plant samples with a non-denaturing detergent-and-inhibitor formulation. This workflow also explains how plant-focused extraction principles can inform mechanistic protein studies without overstating cross-species evidence.

• NSC-23766 Rac GTPase Inhibitor Workflow

  2026-09-07

  NSC-23766 enables controlled interrogation of Rac1-dependent cytoskeletal remodeling, barrier integrity, apoptosis, and cancer-cell growth. This guide connects dose-response design with live-cell phagocytosis assays, helping researchers distinguish Rac1-specific effects from broader toxicity or pathway compensation.

• BIBR 1532: Telomerase Inhibition Workflows

  2026-09-07

  BIBR 1532 enables mechanism-focused studies that separate immediate hTERT inhibition from later telomere attrition and apoptosis. This workflow guide combines telomerase activity assays, leukemia pathway profiling, and carefully controlled comparisons with DNA-damaging telomere strategies.

• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-05

  The preprint reports TRAP-1, a mutant-specific chemical inducer of proximity that brings p53Y220C into a functional complex with BRD4 and restores transcriptional activity. In pancreatic cancer cell models, this mechanism rapidly induced p21 and other p53 target genes while suppressing growth, with ternary-complex-defective controls failing to reproduce the response.

7942 records 1/530 page Next 12345 下5页 Last page